Loading organizations...
Loading organizations...
Pain treatment and development of improved analgesics.
Delova Biotech has raised $21.1M across 2 funding rounds.
Delova Biotech has raised $21.1M in total across 2 funding rounds.
Delova Biotech has raised $21.1M in total across 2 funding rounds.
Delova Biotech's investors include Junlian Capital.
Delova Biotech has raised $21.1M across 2 funding rounds. Most recently, it raised $13.8M Series B in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 2, 2024 | $13.8M Series B | ||
| Sep 14, 2020 | $7.3M Pre-Series A | Junlian Capital |